Liu W - Search Results

1

Risk factors for Japanese encephalitis: a case-control study.

Liu W, Gibbons RV, Kari K, Clemens JD, Nisalak A, Marks F, Xu ZY. Liu W, et al. Epidemiol Infect. 2010 Sep;138(9):1292-7. doi: 10.1017/S0950268810000063. Epub 2010 Jan 29. Epidemiol Infect. 2010. PMID: 20109262

2

[A case-control study on the risk factors of epidemic hemorrhagic fever].

Ruan Y, Liu W, Xu X, Weng S, Zhou W, Deng X, Gu H, Zhu Z, Xu Z. Ruan Y, et al. Among authors: liu w. Zhonghua Liu Xing Bing Xue Za Zhi. 2000 Oct;21(5):344-6. Zhonghua Liu Xing Bing Xue Za Zhi. 2000. PMID: 11860812 Chinese.

3

[Comparative study on antibody levels of vaccination group and control group after 4 years of immunized with type B inactivated vaccine against hemorrhagic fever with renal syndrome].

Ruan Y, Liu W, Xu X, Weng SQ, Shao SK, Zhou WQ, Teng Z, Gu HX, Zhu ZY, Xu ZY. Ruan Y, et al. Among authors: liu w. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2001 Sep;15(3):274-6. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2001. PMID: 11986705 Clinical Trial. Chinese.

4

Clinical characteristics and predictors of the duration of SARS-CoV-2 viral shedding in 140 healthcare workers.

Liu W, Liu Y, Xu Z, Jiang T, Kang Y, Zhu G, Chen Z. Liu W, et al. Among authors: liu y. J Intern Med. 2020 Dec;288(6):725-736. doi: 10.1111/joim.13160. Epub 2020 Sep 21. J Intern Med. 2020. PMID: 32959400 Free PMC article.

5

[A study on immunogenicity and safety of bivalent inactivated vaccine against hemorrhagic fever with renal syndrome].

Ruan Y, Xu X, Liu W, Deng X, Weng S, Zhou W, Wang Q, Chen L, Fang L, Xu Z, Yan Q, Liu W, Dong G, Gu H, Yu Y, Xu Z. Ruan Y, et al. Among authors: liu w. Zhonghua Yu Fang Yi Xue Za Zhi. 1999 Nov;33(6):340-2. Zhonghua Yu Fang Yi Xue Za Zhi. 1999. PMID: 11864504 Clinical Trial. Chinese.

6

Epidemiological and clinical characteristics of severe fever with thrombocytopenia syndrome (SFTS) in China: an integrated data analysis.

Guo CT, Lu QB, Ding SJ, Hu CY, Hu JG, Wo Y, Fan YD, Wang XJ, Qin SL, Cui N, Yang ZD, Zhang XA, Liu W, Cao WC. Guo CT, et al. Among authors: liu w. Epidemiol Infect. 2016 Apr;144(6):1345-54. doi: 10.1017/S0950268815002678. Epub 2015 Nov 6. Epidemiol Infect. 2016. PMID: 26542444 Review.

7

A multinational, observational study to investigate the efficacy, safety and tolerability of acarbose as add-on or monotherapy in a range of patients: the Gluco VIP study.

Zhang W, Kim D, Philip E, Miyan Z, Barykina I, Schmidt B, Stein H; Gluco VIP study. Zhang W, et al. Clin Drug Investig. 2013 Apr;33(4):263-74. doi: 10.1007/s40261-013-0063-3. Clin Drug Investig. 2013. PMID: 23435929

8

Living with COVID-19: a phenomenological study of hospitalised patients involved in family cluster transmission.

Liu W, Liu J. Liu W, et al. Among authors: liu j. BMJ Open. 2021 Feb 26;11(2):e046128. doi: 10.1136/bmjopen-2020-046128. BMJ Open. 2021. PMID: 33637551 Free PMC article.

9

Risk factors for damaged liver function after chemotherapy in hepatitis B virus carriers with non-Hodgkin lymphoma.

Li X, Fan XW, Liu W, Guo L, Li Y, Hu X, Liang X, Ma XP, Yang SE. Li X, et al. Among authors: liu w. Genet Mol Res. 2015 Mar 30;14(1):2647-53. doi: 10.4238/2015.March.30.25. Genet Mol Res. 2015. PMID: 25867413 Free article.

10

Nanostructured lipid carriers as vehicles for transdermal iontophoretic drug delivery.

Liu W, Yang X, Zhu Y, Chen H, Xu H. Liu W, et al. Conf Proc IEEE Eng Med Biol Soc. 2005;2005:1236-9. doi: 10.1109/IEMBS.2005.1616648. Conf Proc IEEE Eng Med Biol Soc. 2005. PMID: 17282417

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

55,548 results

Search Page